| For: | Bergamin CS, Dib SA. Enterovirus and type 1 diabetes: What is the matter? World J Diabetes 2015; 6(6): 828-839 [PMID: 26131324 DOI: 10.4239/wjd.v6.i6.828] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v6/i6/828.htm |
| Number | Citing Articles |
| 1 |
Waled M. El-Senousy, Adel Abdel-Moneim, Mahmoud Abdel-Latif, Mohamed H. EL-Hefnawy, Rehab G. Khalil. Coxsackievirus B4 as a Causative Agent of Diabetes Mellitus Type 1: Is There a Role of Inefficiently Treated Drinking Water and Sewage in Virus Spreading?. Food and Environmental Virology 2018; 10(1) doi: 10.1007/s12560-017-9322-4
|
| 2 |
Wan-Ying Lu, Shan-Jie Rong, Shi-Wei Liu, Chun-Liang Yang, Yue-Chen Liu, Heba H Al-Siddiqi, Fei Sun, Cong-Yi Wang. High-Fat Diet: A Paradoxical Factor in the Setting of Type 1 Diabetes. Nutrition Reviews 2025; doi: 10.1093/nutrit/nuaf184
|
| 3 |
Shao-Chang Wang, Jung-Yu Liao. Epidemiologic Implication of the Association between Herpes Simplex Virus Infection and the Risk of Type 1 Diabetes Mellitus: A Nationwide Case-Control Study in Taiwan. International Journal of Environmental Research and Public Health 2022; 19(13) doi: 10.3390/ijerph19137832
|
| 4 |
Caterina Formichi, Andrea Trimarchi, Carla Maccora, Laura Nigi, Francesco Dotta. Environmental Alteration Leads to Human Disease. Sustainable Development Goals Series 2022; doi: 10.1007/978-3-030-83160-8_14
|
| 5 |
Leila Shakerian, Hanieh Kolahdooz, Mitra Garousi, Vahideh Keyvani, Ramiar Kamal Kheder, Tola Abdulsattar Faraj, Esmaeil Yazdanpanah, Seyed-Alireza Esmaeili. IL-33/ST2 axis in autoimmune disease. Cytokine 2022; 158 doi: 10.1016/j.cyto.2022.156015
|
| 6 |
Laura Nigi, Caterina Formichi, Francesco Dotta. La prevenzione del diabete mellito di tipo 1. L'Endocrinologo 2022; 23(4) doi: 10.1007/s40619-022-01126-0
|
| 7 |
Tanya A. Correya, Ambika P. Ashraf, Russell Griffin, Stella Aslibekyan, Hae dong Kim, Sydney Middleton, Kenneth McCormick. Temporal trends in incidence of pediatric type 1 diabetes in Alabama: 2000‐2017. Pediatric Diabetes 2020; 21(1) doi: 10.1111/pedi.12927
|
| 8 |
F. Badia‐Boungou, F. Sane, E.K. Alidjinou, M. Ternois, P.A. Opoko, J. Haddad, C. Stukens, C. Lefevre, I. Gueorguieva, M. Hamze, M. Ismail, J. Weill, H.G. Monabéka, E. Bouenizabila, D. Moukassa, A.A. Abena, D. Hober. Marker of coxsackievirus‐B4 infection in saliva of patients with type 1 diabetes. Diabetes/Metabolism Research and Reviews 2017; 33(7) doi: 10.1002/dmrr.2916
|
| 9 |
Enagnon Kazali Alidjinou, Famara Sane, Christine Lefevre, Agathe Baras, Ilham Moumna, Ilka Engelmann, Marie-Christine Vantyghem, Didier Hober. Enteroviruses in blood of patients with type 1 diabetes detected by integrated cell culture and reverse transcription quantitative real-time PCR. Acta Diabetologica 2017; 54(11) doi: 10.1007/s00592-017-1041-7
|
| 10 |
Maria K. Smatti, Farhan S. Cyprian, Gheyath K. Nasrallah, Asmaa A. Al Thani, Ruba O. Almishal, Hadi M. Yassine. Viruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms. Viruses 2019; 11(8) doi: 10.3390/v11080762
|
| 11 |
Mahsa Taherzadeh, Abolghasem Esmaeili, Mohamad Reza Ganjalikhany. In silico vaccine design against type 1 diabetes based on molecular modeling of coxsackievirus B4 epitopes. Network Modeling Analysis in Health Informatics and Bioinformatics 2016; 5(1) doi: 10.1007/s13721-016-0112-y
|
| 12 |
Richard E. Lloyd, Manasi Tamhankar, Åke Lernmark. Enteroviruses and Type 1 Diabetes: Multiple Mechanisms and Factors?. Annual Review of Medicine 2022; 73(1) doi: 10.1146/annurev-med-042320-015952
|
| 13 |
Wael A H Hegazy, Azza A H Rajab, Amr S Abu Lila, Hisham A Abbas. Anti-diabetics and antimicrobials: Harmony of mutual interplay. World Journal of Diabetes 2021; 12(11): 1832-1855 doi: 10.4239/wjd.v12.i11.1832
|
| 14 |
Roberta Ibba, Paola Corona, Francesca Nonne, Paola Caria, Gabriele Serreli, Vanessa Palmas, Federico Riu, Simona Sestito, Maria Nieddu, Roberta Loddo, Giuseppina Sanna, Sandra Piras, Antonio Carta. Design, Synthesis, and Antiviral Activities of New Benzotriazole-Based Derivatives. Pharmaceuticals 2023; 16(3) doi: 10.3390/ph16030429
|
| 15 |
Bo Niklasson, William Klitz, Lisa Juntti-Berggren, Per-Olof Berggren, Lars Lindquist. Effectiveness of Antivirals in a Type 1 Diabetes Model and the Move Toward Human Trials. Viral Immunology 2020; 33(9) doi: 10.1089/vim.2020.0039
|
| 16 |
M Abdel-Latif, A A Abdel-Moneim, M H El-Hefnawy, R G Khalil. Comparative and correlative assessments of cytokine, complement and antibody patterns in paediatric type 1 diabetes. Clinical and Experimental Immunology 2017; 190(1) doi: 10.1111/cei.13001
|
| 17 |
Nicole Hartwig Trier, Niccolo Valdarnini, Ilaria Fanelli, Paolo Rovero, Paul Robert Hansen, Claus Schafer-Nielsen, Evaldas Ciplys, Rimantas Slibinskas, Flemming Pociot, Tina Friis, Gunnar Houen. Peptide Antibody Reactivity to Homologous Regions in Glutamate Decarboxylase Isoforms and Coxsackievirus B4 P2C. International Journal of Molecular Sciences 2022; 23(8) doi: 10.3390/ijms23084424
|
| 18 |
Firas Elmastour, Hela Jaïdane, Mehdi Benkahla, Leila Aguech-Oueslati, Famara Sane, Aymen Halouani, Ilka Engelmann, Antoine Bertin, Moncef Mokni, Jawhar Gharbi, Mahjoub Aouni, Enagnon K. Alidjinou, Didier Hober. Anti-coxsackievirus B4 (CV-B4) enhancing activity of serum associated with increased viral load and pathology in mice reinfected with CV-B4. Virulence 2017; 8(6) doi: 10.1080/21505594.2016.1252018
|
| 19 |
Ikbel Hadj Hassine, Jawhar Gharbi, Bechr Hamrita, Mohammed A. Almalki, José Francisco Rodríguez, Manel Ben M’hadheb. Characterization of Coxsackievirus B4 virus-like particles VLP produced by the recombinant baculovirus-insect cell system expressing the major capsid protein. Molecular Biology Reports 2020; 47(4) doi: 10.1007/s11033-020-05333-6
|
| 20 |
Jesselina Francisco dos Santos Haber, Sandra Maria Barbalho, Jose Augusto Sgarbi, Rafael Santos de Argollo Haber, Roger William de Labio, Lucas Fornari Laurindo, Eduardo Federighi Baisi Chagas, Spencer Luiz Marques Payão. The Relationship between Type 1 Diabetes Mellitus, TNF-α, and IL-10 Gene Expression. Biomedicines 2023; 11(4) doi: 10.3390/biomedicines11041120
|
| 21 |
Feiya Sheng, Mi Li, Jia-Mei Yu, Si-Yu Yang, Liang Zou, Guan-Jun Yang, Le-Le Zhang. IL-33/ST2 axis in diverse diseases: regulatory mechanisms and therapeutic potential. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1533335
|
| 22 |
William Klitz, Bo Niklasson. Extending the Enterovirus Lead: Could a Related Picornavirus be Responsible for Diabetes in Humans?. Microorganisms 2020; 8(9) doi: 10.3390/microorganisms8091382
|
| 23 |
Darijus Veteikis. Anthropogenic and temporal components in a complex trigger of type 1 diabetes suggest the active participation of antipyretics. Medical Hypotheses 2016; 93 doi: 10.1016/j.mehy.2016.05.031
|
| 24 |
F. Rubin, A. Lacan, P. Halimi, P. Bonfils. Otosclerosis. EMC - Otorrinolaringología 2017; 46(2) doi: 10.1016/S1632-3475(17)83972-2
|
| 25 |
M.A. Benkahla, F. Elmastour, F. Sane, A.-C. Vreulx, I. Engelmann, R. Desailloud, H. Jaidane, E.K. Alidjinou, D. Hober. Coxsackievirus-B4E2 can infect monocytes and macrophages in vitro and in vivo. Virology 2018; 522 doi: 10.1016/j.virol.2018.06.010
|
| 26 |
Adebola M. Giwa, Angela Yang, Neha Majety, Kusuma Ananth, Rizwan Ahmed, Mohanraj Sadasivam, Marjan Behzadirad, Zahra Omidian, Tiffany Jackson, Thomas Donner, Abdel R.A. Hamad. Insulin. 2023; doi: 10.1016/B978-0-323-91707-0.00003-6
|